Gluten Sensor Device to Promote Gluten Free Diet Adherence and Quality of Life in Patients With Celiac Disease

Not Applicable

Completed

Brief Summary: The current treatment for celiac disease is a strict 100% gluten free diet. Little is known about the best way to promote adherence to such a strict diet and how to maximize quality of life at the same time.

This pilot will look at the utility of a new innovation to promote gluten free diet adherence - a portable gluten sensor device. Participants will be 30 teenagers and adults with celiac disease recruited from the Celiac Disease Center at Columbia University in New York City. Before and after the intervention, participants will be asked about their adherence to a gluten free diet, quality of life, symptoms, and feelings of anxiety, and depression. This pilot data will help to inform interventions that the investigators hope to test in a larger NIH-funded trial to better understand the best ways to promote adherence and quality of life in celiac patients.

Detailed Description: Little is known about the best ways to promote a strict gluten-free diet while maximizing quality of life in teenagers and adults with celiac disease. The aim of the proposed pilot is to assess the acceptability and feasibility of a novel intervention - a portable gluten sensor device. The sample for this pilot will be 30 teenagers and adults with biopsy confirmed celiac disease recruited from the Celiac Center at Columbia University in New York City. Thirty participants will pilot test a portable gluten sensor device with its associated iPhone app for 3 months. At baseline and three-month follow-up, participants will complete measures of gluten free diet adherence, quality of life,symptoms, anxiety, and depression. At post-only, the investigators will collect in-depth data related to the feasibility and acceptability of the gluten sensor, as well as facilitators and barriers related to how, where, and when it was used. At the completion of the proposed pilot study, the investigators hope to have preliminary data to inform development of gluten sensor interventions that the investigators hope to test in a larger NIH-funded randomized controlled trial. These findings, in combination with a larger trial, have the potential for the development of a new standard of care in the management of patients with celiac disease.

Recruitment & Eligibility

Inclusion Criteria

Individuals >13 years old (15 teenagers and 15 adults), 30 in total with duodenal biopsy-confirmed diagnosis of celiac disease will be recruited to participate.
As we are testing a gluten sensor device, we require that participants are 13 years or older as they will need to be able to operate the gluten sensor device independently

Exclusion Criteria

Arm && Interventions

Group	Intervention	Description
Light use of Nima	Gluten Sensor Dose-Finding Intervention	Ten participants will be randomized to receive 12 capsules every other month (18 capsules for the 3 months which is considered light use).
Moderate use of Nima	Gluten Sensor Dose-Finding Intervention	Ten participants will be randomized to receive 12 capsules per month (36 capsules for the 3 months which is considered moderate use).
Heavy use of Nima	Gluten Sensor Dose-Finding Intervention	Ten participants will be randomized to receive 24 capsules per month (72 capsules for the 3 months which is considered heavy use).

Primary Outcome Measures

Name	Time	Method
Quality of life measure	3 months	A 20-item Celiac Disease-Quality of Life (CD-QOL) survey or 17-item Celiac Disease Pediatric Quality of (CDPQOL) survey. Each of these scales ranges from a minimum of 0 (lowest quality of life) to 100 (highest quality of life).

Secondary Outcome Measures

Name	Time	Method
Adherence to the gluten-free diet	3 months	A 7-item validated CD adherence test (CDAT) survey. Higher scores suggest worse adherence (with scores \>13 indicative of poor adherence)
Depression	3 months	The 21 item Beck Depression Inventory (BDI). This depression scale ranges from 0 (fewer symptoms) to 60 (most symptoms).
Celiac disease symptoms	3 months	Celiac Disease Symptom Diary (CDSD)
Anxiety	3 months	21 item Beck Anxiety Inventory. This anxiety index ranges from 20 (lower anxiety) to 100 (greater anxiety).

Locations (1): Celiac Disease Center at Columbia University
🇺🇸
New York, New York, United States